New research by Kalyan Vamshi Vemulapalli et al. demonstrates that ⁶⁸Ga-DOTA-TATE PET/CT offers a higher detection rate for dpNETs in MEN1 patients compared to conventional CT and MRI - resulting in significant changes to clinical management. 📖 Read the full article: doi.org/10.1530/EO-25-0060

Systemic therapy for metastatic adrenocortical carcinoma (mACC) remains a challenge. A new meta-analysis by S Shekar et al. synthesises prospective trial data to: 💡 Benchmark survival and response 💡 Compare treatment efficacy 💡 Identify gaps for future trials 🔗 doi.org/10.1530/EO-25-0027

Be part of the global #neuroendocrinecancer research conversation in Boston, November 17-19. The NETRF Annual Research Symposium brings together expert researchers to share leading-edge science and learn from each other. Register now: bit.ly/4nQ9goU #NETresearch #cancerresearch

🆕 A retrospective case series by Eleni Armeni et al. from Royal Free Hospital explores the diagnostic & therapeutic complexities of glucagonomas, offering a valuable reference point for clinicians & researchers navigating the field. 🔗Read the article: doi.org/10.1530/EO-24-0083

🌐 Endocrine Oncology has joined LinkedIn! We're excited to connect with the global endocrine oncology community in a new space. Follow us for the latest journal articles, special collections and key updates. 🌐 linkedin.com/company/endocrine-oncology/

New research by Kim Dijke et al. (@nkinl.bsky.social) highlights the differences in disease course of appendiceal NETs & appendiceal goblet cell adenocarcinomas, supporting the exclusion of aGCAs from the group of NENs in the 5th #WHO classification. Read the research: doi.org/10.1530/EO-25-0028

🧠Contribute to Endocrine-Related Cancer's new Special Collection on pituitary tumours! We welcome basic, translational & clinical studies that advance understanding & showcase innovations in the field. 📩Submit your proposal to: [email protected] 🌐More info: bit.ly/4mUXslc

🆕 Tumour Heterogeneity in Neuroendocrine Neoplasms Special Collection #NENs We’re seeking cutting-edge research on the biological & clinical characterisation of NEN heterogeneity, highlighting its impact on prognosis & treatment outcomes. 🌐 More info: bit.ly/4lWsJTc 📢 Submit: [email protected]

🧬 A new systematic review and meta-analysis by M P Aguiar et al. links estrogen-related gene polymorphisms to ovarian cancer occurrence/susceptibility, uncovering variants in CYP17A1, COMT and GSTP1 that may be associated with risk. 🔗 Explore the review #OpenAccess: doi.org/10.1530/EO-25-0007

🌱Endocrine-Related Cancer is officially on LinkedIn! Follow our new profile to stay up to date with the latest articles, special collections and updates from the journal. 🌐 linkedin.com/company/endocrine-related-cancer/ #MedSky #CancerResearch #EndocrineOncology #HormoneCancers

🔬 Latest research by Lara Toffoli et al. investigates the impact of FAK inhibition on GI neuroendocrine tumors (GI-NETs) demonstrating its pivotal role in pathogenesis of GI-NETs & supporting its therapeutic targeting. 👉 Read the full article: doi.org/10.1530/EO-2...

Your research can help advance hormone-dependent cancer treatment and improve patient care. Abstract submissions close Monday 15 Sept: bit.ly/4fqWdqL

Our study on FAK inhibition in GI-NETs reveals its dual role in tumor growth, invasion, and even epigenetic regulation. Grateful to my team for their dedication, and to all colleagues, collaborators, and friends who supported us along the way. 🙏 📄 Open Access: eo.bioscientifica.com/view/journal...

💗 Proud of my young research group 💗 Despite limited resources and many challenges, we published our latest work in @endocrineoncology.bsky.social — an emerging journal with a distinguished editorial board of leading experts. #CancerResearch #FAK #NeuroendocrineTumors #TeamScience

Sponsored by @netrf.org, this $100,000 grant is designed to help an early-career, basic or clinical scientist conduct novel and innovative #NETs research. Learn more: mierf.org/to-apply/ #neuroendocrinecancer #earlycareerresearcher

📈Incidence & prevalence of neuroendocrine neoplasms continues to rise globally. A new review by Jessica Mangion et al. explores global epidemiological data, reviewing trends & differences in incidence rates to improve our understanding of this rise. 🔗 doi.org/10.1530/EO-25-0039

🔍Somatostatin analogues (SSA) can unmask insulinoma in presumed non-functional GEP-NETs. A new case report by Isuru Gamage et al. (@petermaccc.bsky.social‬) presents two cases where SSA unmasked hypoglycaemia due to insulinoma. 📖 Check out the full report: doi.org/10.1530/EO-2...

🧠A new systematic review and meta-analysis by Tatiana Tselovalnikova et al. highlights why long-term monitoring is crucial after cranial irradiation as growth hormone deficiency can develop years post-treatment. 👉Read the full article: doi.org/10.1530/EO-25-0025

Could type 2 diabetes mellitus influence breast cancer outcomes? New research by Ayaan Khurshed et al. explores the impact of T2DM on localised breast cancer. 👉 Read the full article: doi.org/10.1530/EO-24-0039 #BreastCancer #Diabetes #OncologyResearch #T2DM

A new case report by Eleonora Pelle (moffittnews.bsky.social) explores three patients with mesenteric NETs, shedding light on the potential risk of bowel ischemia linked to ¹⁷⁷Lu-DOTATATE treatment. 📖Check out the full report #OpenAccess: doi.org/10.1530/EO-25-0033

Attending #ENDO2025? Come and visit the Bioscientifica booth, 803, to find out more about publishing in Endocrine Oncology! 🙌😄

Are you attending the 24th ENS@T Scientific Meeting? In collaboration with ENS@T, we're inviting submissions from speakers and delegates to our new Special Collection dedicated to the important topics discussed at the meeting. 🔗 buff.ly/OOUSqHl For queries or to submit: 📧 [email protected]

🆕New real-world evidence from Monica Majumder et al. on #lenvatinib treatment in metastatic #ThyroidCancer emphasises the importance of supportive care to maximise early dose intensity and efficacy. 🔎Discover the full article: doi.org/10.1530/EO-2...

📣Call for submissions! Be a part of our special collection celebrating the contributions and leadership of women in Neuroendocrine Tumour (NET) science. Original research, reviews and case reports are all welcome. 📧Submit your proposal to: [email protected]📧

Check out the latest review article in our Theranostics in Neuroendocrine Neoplasms special collection: 'Radioembolization for neuroendocrine tumors: procedure, application and clinical outcomes'. By Li Shen Ho @umcutrecht.bsky.social et al. 🔗Read the full review article: doi.org/10.1530/EO-2...

📢Call for submissions! We're inviting contributions to our special collection, Epidemiology & Genetics, focused on identifying trends in the evolving epidemiological and genetic landscape of endocrine-related tumours. 📨Submit your proposal to: [email protected]

Check out this latest research article by Marie Line El Asmar et al. exploring emergency vs routine presentation in neuroendocrine neoplasia, and how timing impacts outcomes. 🔗 Read the full article here: doi.org/10.1530/EO-25-0012

Could HHLA2 be the next big thing in endocrine-related cancer treatment? A new review by Christiane Gruetzmacher et al. delves into its role as a potential biomarker and immune checkpoint target. 🔗 Read the full article here: doi.org/10.1530/EO-24-0034

📢 Open for submissions! Be a part of our special collection: Epidemiology & Genetics We’re looking for mini-reviews focusing on identifying trends in the evolving epidemiological and genetic landscape of endocrine-related tumours. Submit to: [email protected]

Check out this study by Junko Akaishi et al. exploring the clinicopathological features and prognosis of #HistologicalSubtypes of #PapillaryThyroidCarcinoma in #pediatric patients. 🔗 Read the full article here: doi.org/10.1530/EO-24-0078

Our special collection, Women in Neuroendocrine Tumour Science: Breaking Barriers and Building Legacies, is open for submissions! Join us in celebrating women advancing the field! Submit your article proposal today: [email protected]

Flávia Alves Verza et al. demonstrated for the first time that oral squamous cell #carcinoma cells secrete stress-related #norepinephrine, and this event can be further regulated by the tobacco carcinogen NNK. Read the research here ➡️ buff.ly/0KXYIZ1

Our all new event for 2025 - Hormone Dependent Cancer meeting - is now open for bookings! Explore breakthroughs in breast & prostate cancer research. ✨Officially endorsed by Endocrine Oncology✨ Join us and part of the conversation. 📍 York | 📅 17–18 November 2025

📍 Thyroid differentiation profile for differentiated thyroid cancer By Anthony J McGoron et al. Read it here ➡️ doi.org/10.1530/EO-2...

📍 Acute severe hypocalcaemia after initiation of a selective RET-inhibitor in medullary thyroid cancer By Leslie Cheng et al. Read it here 👉 doi.org/10.1530/EO-2...

Check out this study by Eline N M van Vliembergen et al. providing insights into the natural course of cystic pancreatic #neuroendocrine tumours in #MEN1 ➡️ doi.org/10.1530/EO-2...

Romain L’Huillier et al. evaluate the performances of computed tomography for the surgical planning of small intestine #neuroendocrine #tumours. Read it here 👉 doi.org/10.1530/EO-2...

Read this recent review covering recent advances in #medullary #thyroid #carcinoma treatment, emphasizing surgical and systemic therapies by Mark A Jara and Luciana Audi Castroneves ➡️ doi.org/10.1530/EO-2...

Submit a mini-review to our latest special collection focused on identifying trends in the evolving epidemiological and genetic landscape of endocrine-related tumours. Learn more ➡️ eo.bioscientifica.com/page/epidemi... It's currently free of charge to publish open access in Endocrine Oncology!

In this review, Irene Hunter et al. discuss the structural properties of the #androgen receptor and highlight some promising preclinical and clinical studies that aim to develop a drug discovery pipeline of small-molecule inhibitors targeting the amino-terminal domain 👉 doi.org/10.1530/EO-2...

Congratulations to our pipette challenge winners at #ENETS2025 👏 Thank you to everyone that came by the booth and took part🤝 Until next time ✨

Day 3 at #ENETS2025! Pictured is Editor-in-Chief Justo Castaño ( @justocastano.bsky.social ) finishing up his talk on best basic science NET publications of the year! ✨ if you’d like to find out more information on Endocrine Oncology visit eo.bioscientifica.com

📸 Endocrine Oncology publishing team and our Deputy Editor Simona Glasberg ( @simonaglasberg.bsky.social ) at #ENETS2025 in Kraków! @enets.bsky.social

It is our last day exhibiting at #ENETS2025 - if you haven't already come by our booth to pick up a free copy of our sample booklet🤝 @enets.bsky.social

Associate Editor Prof Rachel Riechelmann during her talk at #ENETS2025 yesterday 🌟 Meet more of the Endocrine Oncology team at the Bioscientifica booth 🙌🏻 @enets.bsky.social

We're here at #ENETS2025 with Editor-in-Chief @justocastano.bsky.social , publisher Katherine and publishing assistant Brittany, representing the journal in beautiful Kraków! If you're attending the conference come tell us about your next publication 🤝

Showcase your research in @Soc_Endo's Special Collection, highlighting the contributions of early career members in #endocrine #cancer. With the APC currently waived, it's a fantastic chance to publish your work at no cost. Learn more 👉 buff.ly/3QBL7DL

#ENETS2025 visit the @Bioscientifica stand and pick up a Endocrine Oncology sample booklet featuring a section of recently-published abstracts on the interplay between hormones and cancer, and related topics!

Hello 👋 #ENETS2025 ✨ Come and say hello at the Bioscientifica stand 8, take on the pipette challenge and learn about publishing in Endocrine Oncology 🙌🏻

Our latest Special Collection celebrates the contributions and leadership of women in Neuroendocrine Tumour science, who are breaking barriers and building legacies. Submit your article proposal to contribute to this important collection. Learn more 👉 eo.bioscientifica.com/page/Women-i...